ProteinsBoltz-2

Boltz-2 vs AlphaFold3: Biomolecular Complex Prediction Compared

Head-to-head comparison of Boltz-2 and AlphaFold3. Compare accuracy, speed, licensing, input types, and API availability for biomolecular complex prediction.

Ryan Bethencourt
March 26, 2026
10 min read

Two Approaches to Complex Prediction

AlphaFold3 and Boltz-2 represent the current state of the art in biomolecular complex structure prediction. Both use diffusion-based generative models to predict the 3D geometry of molecular complexes involving proteins, nucleic acids, and small molecules. Despite sharing similar architectural principles, they differ significantly in accessibility, licensing, and practical usability.

This comparison covers the technical differences, benchmark results, and practical considerations that matter when choosing between the two for research or production workflows.

AlphaFold3: DeepMind's Closed Model

AlphaFold3 was published by Google DeepMind in May 2024 in Nature. It extends the AlphaFold series from single-chain protein folding to general biomolecular complex prediction. The model handles proteins, DNA, RNA, small molecules, ions, and post- translational modifications.

  • Developer: Google DeepMind / Isomorphic Labs
  • Architecture: diffusion-based generative model with Pairformer attention
  • Weights: not publicly available (closed source)
  • Access: AlphaFold Server (alphafoldserver.com) with daily prediction limits
  • License: non-commercial research only via the server; no local deployment
  • Inputs: protein, DNA, RNA, small molecules, ions, modified residues
Warning
The AlphaFold Server restricts usage to non-commercial academic research and limits the number of predictions per user per day. There is no API for programmatic access, and results cannot be used in commercial drug discovery pipelines.

Boltz-2: MIT's Open-Source Alternative

Boltz-2 was developed by researchers at MIT and released as a fully open-source model with downloadable weights. It reproduces the core architectural ideas from AlphaFold3 and achieves comparable accuracy on standard benchmarks while removing all access restrictions.

  • Developer: MIT (Genesis Therapeutics collaboration)
  • Architecture: diffusion-based generative model with pairwise attention
  • Weights: publicly available (open source)
  • Access: local GPU deployment or SciRouter API
  • License: open source, commercial use permitted
  • Inputs: protein, DNA, RNA, small molecules

Accuracy Comparison

Protein-Protein Complexes

On protein-protein interface prediction benchmarks, both models achieve DockQ scores above 0.5 for most heterodimer targets. AlphaFold3 shows a slight advantage on targets with limited evolutionary information, while Boltz-2 performs comparably on well-characterized protein families.

Protein-Ligand Complexes

For protein-small molecule complex prediction, Boltz-2 and AlphaFold3 produce ligand binding poses within 2 angstroms RMSD of the crystal pose for approximately 40 to 50 percent of targets. This is a challenging task, and both models represent a significant improvement over traditional docking for blind binding pose prediction.

Nucleic Acid Complexes

AlphaFold3 was specifically highlighted for its accuracy on protein-DNA and protein-RNA complexes. Boltz-2 also supports these input types and performs well, though detailed comparative benchmarks are still emerging.

Practical Differences

  • API access: Boltz-2 is available through the SciRouter API for programmatic use; AlphaFold3 is only accessible via a web interface with manual submission
  • Batch processing: Boltz-2 via API supports parallel job submission for screening campaigns; AlphaFold Server has daily limits
  • Commercial use: Boltz-2 is freely usable in commercial drug discovery; AlphaFold3 is restricted to non-commercial research
  • Customization: Boltz-2 weights can be fine-tuned on proprietary data; AlphaFold3 cannot be modified
  • Reproducibility: Boltz-2 results are fully reproducible with local deployment; AlphaFold Server versions may change without notice

Using Boltz-2 via SciRouter API

Here is a complete example of predicting a protein-ligand complex structure using Boltz-2 through the SciRouter API:

Protein-ligand complex prediction with Boltz-2
import requests
import time

API_KEY = "sk-sci-your-api-key"
BASE = "https://api.scirouter.ai/v1"
headers = {"Authorization": f"Bearer {API_KEY}"}

# Predict a kinase-inhibitor complex
response = requests.post(
    f"{BASE}/proteins/complex",
    headers=headers,
    json={
        "model": "boltz2",
        "chains": [
            {
                "type": "protein",
                "sequence": "MKKFISFLLTATAAVSGAPVQGEEKLVETDPKQLISGKLNVSKATYKEL"
            }
        ],
        "ligands": [
            {"smiles": "CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5"}
        ]
    }
)
job_id = response.json()["job_id"]

# Poll for results
while True:
    result = requests.get(
        f"{BASE}/proteins/complex/{job_id}",
        headers=headers
    ).json()
    if result["status"] == "completed":
        print(f"Complex predicted. Confidence: {result['confidence']:.2f}")
        print(f"Interface pTM: {result['interface_ptm']:.2f}")
        with open("complex.pdb", "w") as f:
            f.write(result["pdb"])
        break
    elif result["status"] == "failed":
        print(f"Error: {result['error']}")
        break
    time.sleep(10)

When to Use Which

The choice between AlphaFold3 and Boltz-2 depends on your specific situation:

  • Use AlphaFold3 if you are doing non-commercial academic research, need a quick one-off prediction, and are comfortable with a web interface
  • Use Boltz-2 if you need API access, batch processing, commercial use rights, reproducible results, or the ability to fine-tune the model
  • Use both as a consensus approach: run both models and compare results to increase confidence in predictions
Tip
For single-chain protein structure prediction (not complexes), consider ESMFold which is significantly faster than both Boltz-2 and AlphaFold3.

Try Boltz-2 from the SciRouter tools page. For more background on how Boltz-2 works, read our introduction to Boltz-2.

Frequently Asked Questions

Which is more accurate, Boltz-2 or AlphaFold3?

On published benchmarks, AlphaFold3 and Boltz-2 perform comparably on protein-ligand and protein-protein complex prediction. AlphaFold3 shows a slight edge on certain nucleic acid complexes, while Boltz-2 performs well on protein-small molecule targets. The differences are small enough that choice of tool should be driven by practical factors like licensing, speed, and API availability rather than accuracy alone.

Can I use AlphaFold3 commercially?

AlphaFold3 model weights are not publicly available for commercial use. Google DeepMind provides access through the AlphaFold Server, which is restricted to non-commercial academic research with limits on the number of predictions per day. Boltz-2 is fully open-source and can be used commercially without restrictions.

Does Boltz-2 support small molecule ligands?

Yes. Boltz-2 natively supports small molecules specified as SMILES strings. The model predicts the 3D binding pose of the ligand within the protein complex. This makes it suitable for drug-target complex prediction without requiring a separate docking step.

Which model is faster?

Boltz-2 inference typically takes 1 to 5 minutes per complex on an A100 GPU, depending on total system size. AlphaFold3 speed data is not publicly available since it runs on Google infrastructure. Through SciRouter, Boltz-2 predictions complete in 30 seconds to 5 minutes depending on complexity.

Try It Free

No Login Required

Try this yourself

500 free credits. No credit card required.